• Careers

  • News

  • Healthcare Professionals

  • Adverse Event Reporting

  • Contact us

    • Email Us

    • Call Us

    • Privacy Policy

    • Terms &Conditions

  • Career-Seekers

  • News & Media

  • Healthcare Professionals

  • Connect With Us

  • Terms and Conditions

  • Privacy Policy

  • Adverse Event Reporting

  • Change Region

  • Site Map

INJECTABLES AND ANTI‑INFECTIVES

Treating bacterial, fungal and parasitic infections
​​​​​​​​​​​​​​
​​​​​​​
In 1943, Pfizer pioneered the process of deep-tank fermentation and became the first company to mass produce the life-saving penicillin. This drug was delivered to the frontlines of World War II and used to treat over 1,50,000 soldiers wounded in the D-Day landings, and countless others during the war.(1,2)

Helix Image

Since then, we have discovered and introduced some of the best -known and preferred antimicrobials and maintained our position as one of the leading global antimicrobials company with more than 80 antimicrobial agents used to treat bacterial, fungal and parasitic infections.(3)

In India, our Hospitals team is part of the Innovative Medicines portfolio and is helping to commercialize our global portfolio of sterile injectables and anti-infective medicines. Our large and diverse anti-infectives portfolio extends across the spectrum, from commonly used beta-lactam- beta-lactamase-inhibitors to high-end antibacterial and antifungal products. Our anti-infectives team focuses on providing high quality advanced anti-infectives for use in critical care in hospitals, including for the treatment of invasive fungal and resistant bacterial infections.

Over the years, we have developed a legacy of leadership in anti-infectives, bringing to market advanced antimicrobials to tackle some of the most difficult diseases that impact public health. As we strive to bring newer, more effective antibiotics and antifungals to treat infections, we also lead the fight against anti-microbial resistance (AMR), a phenomenon that is making today’s antimicrobials less effective in treating rapidly evolving pathogens.(4)

Refs:

1. The Journey | Pfizer. [online] Available at: <https://www.pfizer.com/people/history> [Accessed 23 September 2021].

2. Flavell-While, C., 2017. Pfizer's Penicillin Pioneers – Jasper Kane and John McKeen. [online] Thechemicalengineer.com. Available at: <https://www.thechemicalengineer.com/features/cewctw-pfizers-penicillin-pioneers-jasper-kane-and-john-mckeen/> [Accessed 23 September 2021].

3. Our Commitment As A Global Anti-Infectives Leader | Pfizer. [online] Available at: <https://www.pfizer.com/science/therapeutic-areas/anti-infectives/global-anti-infectives-leader> [Accessed 23 September 2021].
​​​​​​​
4. Annual Report 2020-21. [online] Available at: <https://www.pfizerindia.com/eNewsWebsite/investor/pdf/Pfizer_Limited_Annual_Report_2020-21.pdf> [Accessed 23 September 2021].

Disclaimer:
​​​​​​​
This information—including product information—is intended only for residents of India. The products discussed herein may have different labelling in different countries. Patients should always ask their doctors for medical advice.

PP-CPF-IND-0035 | 11/11/21

  • Vaccines

  • Oncology

  • Internal Medicine

  • Rare Diseases

  • Inflammation and Immunology

about usPfizer IncOur Legacy​​​​​​​Our Purpose & Values​​​​​​​Pfizer's Code of ConductPfizer in India​​​​​Our ManufacturingOur Distribution Networkour scienceFocus AreasR&D SupportClinical Trials in Indiaour peopleWorking at PfizerOur Culture & ValuesCareers at Pfizer#BeTheBreakthroughDiversity and InclusionGreat Place To Workour community effortsCSR VisionCSR IntiativeCSR Volunteeringyour healthDisease & ConditionsManaging Your HealthBiology Explained